Long-Term Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry)

American Journal of Cardiology

Volumn 101, Issue 7, 2008, Pages 947-952

  Vignali, Luigi ^a   Saia, Francesco ^b   Manari, Antonio ^e   Santarelli, Andrea ^f   Rubboli, Andrea ^c   Varani, Elisabetta ^g   Piovaccari, Giancarlo ^f   Menozzi, Alberto ^a   Percoco, Gianfranco ^h   Benassi, Alberto ⁱ   Rusticali, Guido ^j   Marzaroli, Paolo ^d   Guastaroba, Paolo ^d   Grilli, Roberto ^d   Maresta, Aleardo ^g   Marzocchi, Antonio ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

^d Regional Health Care Agency   (Italy)

^e S MARIA NUOVA HOSPITAL   (Italy)

^f INFERMI HOSPITAL   (Italy)

^g SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^h S ANNA HOSPITAL   (Italy)

ⁱ HESPERIA HOSPITAL   (Italy)

^j GUGLIELMO DA SALICETO HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RAPAMYCIN; TICLOPIDINE;

AGE DISTRIBUTION; AGED; ARTICLE; BARE METAL STENT; CARDIOGENIC SHOCK; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LOADING DRUG DOSE; LONG TERM CARE; MALE; MORTALITY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; SEX DIFFERENCE; THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; SAPHENOUS VEIN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 41249085132     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.055     Document Type: Article

References (17)

1. Bourassa M.G., Fisher L.D., Campeau L., Gillespie M.J., McConney M., and Lesperance J. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute Experiences. Circulation 72 suppl (1985) V71-V78
2. FitzGibbon G.M., Leach A.J., Kafka H.P., and Keon W.J. Coronary bypass graft fate: Long-term angiographic study. J Am Coll Cardiol 17 (1991) 1975-1980
3. Fitzgibbon G.M., Kafka H.P., Leach A.J., Keon W.J., Hooper G.D., and Burton J.R. Coronary bypass graft fate and patients outcome: angiographic follow-up of 5,065 graft related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28 (1996) 616-626
4. Savage M.P., Douglas J.S., Fischman D.L., Pepine C.J., King S.B., Werner J.A., Bailey S.R., Overlie P.A., Fenton S.H., Brinker J.A., Leon M.B., and Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators. N Engl J Med 337 (1997) 740-747
5. Hanekamp C.E., Koolen J.J., Den Heijer P., Schalij M.J., Piek J.J., Bär F.W., De Scheerder I., Bonnier H.J., Pijls N.H., and Venestent Study Group. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: the Venestent study. Catheter Cardiovasc Interv 60 (2003) 452-457
6. Frimerman A., Rechavia E., Eigler N., Payton M.R., Makkar R., and Litvack F. Long-term follow-up of a high risk cohort after stent implantation in saphenous vein grafts. J Am Coll Cardiol 30 (1997) 1277-1283
7. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
8. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., and Russell M.E. Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesion. Circulation 108 (2003) 788-794
9. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R., and RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Eng J Med 346 (2002) 1773-1780
10. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
11. Keeley E.C., Velez C.A., O'Neill W.W., and Safian R.D. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein graft. J Am Coll Cardiol 38 (2001) 659-666
12. Strauss B.H., Serruys P.W., Bertrand M.E., Puel J., Meier B., Goy J.J., Kappenberger L., Rickards A.F., and Sigwart U. Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass graft. Am J Cardiol 69 (1992) 475-481
13. Safian R.D., Kaplan B., Schreiber T., Waters J., Moses J., and Leon M.H. Final results of the randomized Wallstent endoprosthesis in saphenous vein graft trial (WINS). J Am Coll Cardiol 33 suppl (1999) 37A
14. Ge L., Iakovou I., Sangiorgi G.M., Chieffo A., Melzi G., Cosgrave J., Montorfano M., Michev I., Airoldi F., Carlino M., Corvaja N., and Colombo A. Treatment of saphenous vein graft lesions with drug-eluting stents. J Am Coll Cardiol 45 (2005) 989-994
15. Lee M.S., Shah A.P., Aragon J., Jamali A., Dohad S., Kar S., and Makkar R.R. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 66 (2005) 507-511
16. Brunner-La Rocca H.P., Kaiser C., Pfisterer M., and BASKET Investigators. Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET). Eur Heart J 28 (2007) 719-725
17. Vermeersch P., Agostoni P., Verheye S., Van den Heuvel P., Convens C., Van den Branden F., Van Langenhove G., and DELAYED RRISC (Death and Events at Long-term follow-up Analysis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol 50 (2007) 261-267